Fresenius SE & Co. (OTCMKTS:FSNUY) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Fresenius SE & Co. (OTCMKTS:FSNUY) released its earnings results on Wednesday. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01), Zacks reports. Fresenius SE & Co. had a net margin of 5.71% and a return on equity of 10.31%.

Fresenius SE & Co. Stock Up 2.6%

Shares of OTCMKTS:FSNUY traded up $0.30 during midday trading on Wednesday, reaching $11.91. The company had a trading volume of 70,514 shares, compared to its average volume of 142,768. The company has a quick ratio of 1.00, a current ratio of 1.32 and a debt-to-equity ratio of 0.47. The business’s 50 day moving average price is $13.13 and its 200 day moving average price is $14.16. The stock has a market cap of $26.83 billion, a PE ratio of 18.91 and a beta of 0.68. Fresenius SE & Co. has a 1-year low of $11.28 and a 1-year high of $33.93.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, April 20th. Citigroup reiterated a “buy” rating on shares of Fresenius SE & Co. in a report on Tuesday, February 3rd. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, Fresenius SE & Co. presently has a consensus rating of “Buy”.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.